Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants

Journal of Pediatrics

Volumn 164, Issue 5, 2014, Pages

  Dobson, Nicole R ^a   Patel, Ravi M ^b   Smith, P Brian ^c   Kuehn, Devon R ^d   Clark, Jennifer ^e   Vyas Read, Shilpa ^b   Herring, Amy ^e   Laughon, Matthew M ^f   Carlton, David ^b   Hunt, Carl E ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d WOMACK ARMY MEDICAL CENTER   (United States)

^e University of North Carolina at Chapel Hill   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

BPD; Bronchopulmonary dysplasia; Caffeine for Apnea of Prematurity; CAP; Continuous positive airway pressure; CPAP; Day of life; DOL; Fraction of inspired oxygen; GA; Gestational age; HFOV; High frequency oscillatory ventilation; Intraventricular hemorrhage; IVH; Mechanical ventilation; MV; NEC; Necrotizing enterocolitis; Patent ductus arteriosus; PDA; Propensity score; PS; Retinopathy of prematurity; ROP; Very low birth weight; VLBW

Indexed keywords

CAFFEINE;

ARTICLE; ARTIFICIAL VENTILATION; CHRONOTHERAPY; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN CARE; NEWBORN DEATH; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; TREND STUDY; VERY LOW BIRTH WEIGHT;

BRONCHOPULMONARY DYSPLASIA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG ADMINISTRATION SCHEDULE; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INCIDENCE; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROPENSITY SCORE; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME; UNITED STATES;

EID: 84899093344     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.12.025     Document Type: Article

References (38)

1. R.H. Clark, B.T. Bloom, A.R. Spitzer, and D.R. Gerstmann Reported medication use in the neonatal intensive care unit: data from a large national data set Pediatrics 117 2006 1979 1987
2. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, and A. Ohlsson et al. Caffeine therapy for apnea of prematurity N Engl J Med 354 2006 2112 2121
3. B. Schmidt, P.J. Anderson, L.W. Doyle, D. Dewey, R.E. Grunau, and E.V. Asztalos et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity JAMA 307 2012 275 282
4. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, and A. Ohlsson et al. Long-term effects of caffeine therapy for apnea of prematurity N Engl J Med 357 2007 1893 1902
5. J.V. Aranda, T. Turmen, J. Davis, T. Trippenbach, D. Grondin, and R. Zinman et al. Effect of caffeine on control of breathing in infantile apnea J Pediatr 103 1983 975 978
6. J.M. Davis, V.K. Bhutani, J.L. Stefano, W.W. Fox, and A.R. Spitzer Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia Pediatr Pulmonol 6 1989 49 52
7. G.S. Supinski, E.C. Deal Jr., and S.G. Kelsen The effects of caffeine and theophylline on diaphragm contractility Am Rev Respir Dis 130 1984 429 433
8. B. Yoder, M. Thomson, and J. Coalson Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: a pilot study Acta Paediatr 94 2005 92 98
9. U. Weichelt, R. Cay, T. Schmitz, E. Strauss, M. Sifringer, and C. Bührer et al. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine Eur Respir J 41 2013 966 973
10. J. Li, G. Li, J.L. Hu, X.H. Fu, Y.J. Zeng, and Y.G. Zhou et al. Chronic or high-dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism Eur J Pharmacol 654 2011 295 303
11. I.S. Oliveira Jr., B.V. Pinheiro, I.D. Silva, R. Salomao, R.L. Zollner, and O.S. Beppu Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume Braz J Med Biol Res 36 2003 1349 1357
12. P.G. Davis, B. Schmidt, R.S. Roberts, L.W. Doyle, E. Asztalos, and R. Haslam et al. Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups J Pediatr 156 2010 382 387
13. R.M. Patel, T. Leong, D.P. Carlton, and S. Vyas-Read Early caffeine therapy and clinical outcomes in extremely preterm infants J Perinatol 33 2013 134 140
14. J. Bhatia Current options in the management of apnea of prematurity Clin Pediatr (Phila) 39 2000 327 336
15. D.J. Henderson-Smart, and A.G. De Paoli Methylxanthine treatment for apnoea in preterm infants Cochrane Database Syst Rev 2010 CD000140
16. A.R. Spitzer, D.L. Ellsbury, D. Handler, and R.H. Clark The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system - tools for "meaningful use" in continuous quality improvement Clin Perinatol 37 2010 49 70
17. P.C. Austin A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality Multivariate Behav Res 46 2011 119 151
18. M.A. Brookhart, S. Schneeweiss, K.J. Rothman, R.J. Glynn, J. Avorn, and T. Sturmer Variable selection for propensity score models Am J Epidemiol 163 2006 1149 1156
19. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Available from: http://www2.sas.com/proceedings/ sugi26/p214-26.pdf. Accessed January 17, 2013.
20. N.N. Finer, W.A. Carlo, M.C. Walsh, W. Rich, M.G. Gantz, and A.R. Laptook et al. Early CPAP versus surfactant in extremely preterm infants N Engl J Med 362 2010 1970 1979
21. V. Soloveychik, A. Bin-Nun, A. Ionchev, S. Sriram, and W. Meadow Acute hemodynamic effects of caffeine administration in premature infants J Perinatol 29 2009 205 208
22. I. Gillot, J.B. Gouyon, and J.P. Guignard Renal effects of caffeine in preterm infants Biol Neonate 58 1990 133 136
23. 2+ stores in vascular smooth muscle: functional implications Novartis Found Symp 246 2002 125 137
24. A.R. Whorton, J.B. Collawn, M.E. Montgomery, S.L. Young, and R.S. Kent Arachidonic acid metabolism in cultured aortic endothelial cells: effect of cAMP and 3-isobutyl-1-methylxanthine Biochem Pharmacol 34 1985 119 123
25. T.R. Hartley, W.R. Lovallo, and T.L. Whitsett Cardiovascular effects of caffeine in men and women Am J Cardiol 93 2004 1022 1026
26. B.E. Stephens, R.A. Gargus, R.V. Walden, M. Mance, J. Nye, and L. McKinley et al. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants J Perinatol 28 2008 123 128
27. J. Bauer, K. Maier, O. Linderkamp, and R. Hentschel Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea Pediatrics 107 2001 660 663
28. S.E. Hamrick, and G. Hansmann Patent ductus arteriosus of the preterm infant Pediatrics 125 2010 1020 1030
29. B. Schmidt, P. Davis, D. Moddemann, A. Ohlsson, R.S. Roberts, and S. Saigal et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants N Engl J Med 344 2001 1966 1972
30. J.M. Di Fiore, F. Kaffashi, K. Loparo, A. Sattar, M. Schluchter, and R. Foglyano et al. The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants Pediatr Res 72 2012 606 612
31. C. Hoecker, M. Nelle, J. Poeschl, B. Beedgen, and O. Linderkamp Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants Pediatrics 109 2002 784 787
32. M.B. Tracy, J. Klimek, M. Hinder, G. Ponnampalam, and S.K. Tracy Does caffeine impair cerebral oxygenation and blood flow velocity in preterm infants? Acta Paediatr 99 2010 1319 1323
33. B. Schmidt, R. Roberts, D. Millar, and H. Kirpalani Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very low birth weight infants Neonatology 93 2008 284 287
34. M.M. Laughon, J.C. Langer, C.L. Bose, P.B. Smith, N. Ambalavanan, and K.A. Kennedy et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants Am J Respir Crit Care Med 183 2011 1715 1722
35. J.E. Tyson, N.A. Parikh, J. Langer, C. Green, and R.D. Higgins Intensive care for extreme prematurity - moving beyond gestational age N Engl J Med 358 2008 1672 1681
36. A.A. Fanaroff, B.J. Stoll, L.L. Wright, W.A. Carlo, R.A. Ehrenkranz, and A.R. Stark et al. Trends in neonatal morbidity and mortality for very low birthweight infants Am J Obstet Gynecol 196 2007 147.e1 147.e8
37. C. Ruegger, M. Hegglin, M. Adams, and H.U. Bucher Population-based trends in mortality, morbidity and treatment for very preterm and very low birth weight infants over 12 years BMC Pediatr 12 2012 17
38. M.C. Walsh, D. Wilson-Costello, A. Zadell, N. Newman, and A. Fanaroff Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia J Perinatol 23 2003 451 456